51. Ranolazine attenuation of CFA-induced mechanical hyperalgesia
- Author
-
Harry J. Gould, Ivan Diamond, Dennis Paul, Jomar S. Roberts, and Gregory P. Casey
- Subjects
Male ,Hot Temperature ,medicine.medical_treatment ,Sodium ,Freund's Adjuvant ,chemistry.chemical_element ,Ranolazine ,Administration, Oral ,Stimulation ,Piperazines ,Rats, Sprague-Dawley ,Physical Stimulation ,medicine ,Animals ,Enzyme Inhibitors ,Saline ,Pain Measurement ,business.industry ,Foot ,Sodium channel ,General Medicine ,Rats ,Anesthesiology and Pain Medicine ,Allodynia ,chemistry ,Freund's adjuvant ,Hyperalgesia ,Anesthesia ,Acetanilides ,Neurology (clinical) ,medicine.symptom ,business ,Injections, Intraperitoneal ,medicine.drug - Abstract
Objective. To determine whether ranolazine, a newanti-angina medication, could be an effective anal-gesic agent in complete Freund’s adjuvant-inducedinflammatory pain.Background. Plantar injection of complete Freund’sadjuvant (CFA) produces an extended period ofhyperalgesia that is associated with a dramaticup-regulation of Na v 1.7 sodium channels in popula-tions of large and small dorsal root ganglionneurons related to the injection site. Ranolazineappears to produce its anti-angina effect throughblocking the late sodium current associated with thevoltage-gated sodium channel, Na v 1.5. Becauseranolazine also inhibits Na v 1.7, and 1.8, we soughtto determine whether it could be an effective anal-gesic agent in CFA-induced inflammatory pain.Methods. Baseline determinations of withdrawalfrom thermal and mechanical stimulation were madein Sprague-Dawley rats ( ~ 300–350 ¥ g ). Followingdetermination of baseline, one hindpaw in eachgroup was injected with 0.1 mL of CFA. The con-tralateral paw received saline. Thermal andmechanical stimulation was repeated on the thirdday post-injection. Vehicle (0.9% isotonic saline;pH 3.0) or ranolazine was then administered in ran-domized and blinded doses either by intraperitoneal(ip) injection (0, 10, 20, and 50 mg/kg) or by oralgavage (po; 0, 20, 50, 100, and 200 mg/kg). Animalswere again tested 30 minutes (ip) and 1 hour (po)after drug administration.Results. Ranolazine produced dose-dependantanalgesia on mechanical allodynia induced by CFAinjection, but had no effect on thermal hyperalgesia.Conclusions. Ranolazine’s potential as a newoption for managing both angina and chronicinflammatory pain warrants further study.Key Words. Ranolazine; CFA; Pain; AllodyniaIntroduction
- Published
- 2010